MINERALYS THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
MINERALYS THERAPEUTICS, INC. (MLYS) had Common Stock, Capital Shares Reserved for Future Issuance of 13.91 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-11
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 13.91M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 14.15M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 10.42M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 10.84M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 13.91M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 14.15M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 10.42M shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 10.84M shares 10-Q · filed 2025-11-10 |
| 2025-06-30 | 11.57M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 11.74M shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 8.40M shares 10-K · filed 2025-02-12 |
| 2024-09-30 | 8.46M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 8.53M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 8.58M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 6.14M shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 6.17M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 6.42M shares 10-Q · filed 2023-08-07 |
| 2023-03-31 | 6.42M shares 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |